12.04.2024 03:07:54

Nyxoah Appoints Maurits Boon As Chief Medical Officer

(RTTNews) - Nyxoah SA (NYXH) said that it appointed Maurits Boon as Chief Medical Officer.

Boon joins Nyxoah from the Thomas Jefferson University, where he will continue part time as a professor and Vice Chairman, Education. He is dual board-certified in otolaryngology - head and neck surgery, as well as sleep medicine.

Boon is one of two sleep surgeons with Jefferson Health to pioneer the use of hypoglossal nerve stimulation therapy. He has lectured worldwide on obstructive sleep apnea, has numerous publications and is co-editor of the first book on hypoglossal nerve stimulation therapy.

Analysen zu Nyxoah S.A. Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Nyxoah S.A. Registered Shs 11,25 4,65% Nyxoah S.A. Registered Shs